Nathan B Fountain - Net Worth and Insider Trading
Nathan B Fountain Net Worth
The estimated net worth of Nathan B Fountain is at least $16,750 dollars as of 2024-11-13. Nathan B Fountain is the Director of Acumen Pharmaceuticals Inc and owns about 6,250 shares of Acumen Pharmaceuticals Inc (ABOS) stock worth over $16,750. Details can be seen in Nathan B Fountain's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Nathan B Fountain has not made any transactions after 2021-07-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Nathan B Fountain
Nathan B Fountain Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Nathan B Fountain owns 1 companies in total, including Acumen Pharmaceuticals Inc (ABOS) .
Click here to see the complete history of Nathan B Fountain’s form 4 insider trades.
Insider Ownership Summary of Nathan B Fountain
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ABOS | Acumen Pharmaceuticals Inc | 2021-07-06 | director |
Nathan B Fountain Latest Holdings Summary
Nathan B Fountain currently owns a total of 1 stock. Nathan B Fountain owns 6,250 shares of Acumen Pharmaceuticals Inc (ABOS) as of July 6, 2021, with a value of $16,750.
Latest Holdings of Nathan B Fountain
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ABOS | Acumen Pharmaceuticals Inc | 2021-07-06 | 6,250 | 2.68 | 16,750 |
Holding Weightings of Nathan B Fountain
Nathan B Fountain Form 4 Trading Tracker
According to the SEC Form 4 filings, Nathan B Fountain has made a total of 1 transactions in Acumen Pharmaceuticals Inc (ABOS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Acumen Pharmaceuticals Inc is the acquisition of 6,250 shares on July 6, 2021, which cost Nathan B Fountain around $100,000.
Insider Trading History of Nathan B Fountain
- 1
Nathan B Fountain Trading Performance
GuruFocus tracks the stock performance after each of Nathan B Fountain's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Nathan B Fountain is -26.49%. GuruFocus also compares Nathan B Fountain's trading performance to market benchmark return within the same time period. The performance of stocks bought by Nathan B Fountain within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Nathan B Fountain's insider trading performs compared to the benchmark.
Performance of Nathan B Fountain
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -25.69 | | | | | |
| Relative Return to S&P 500(%) | -27.83 | | | | | |
Nathan B Fountain Ownership Network
Ownership Network List of Nathan B Fountain
Ownership Network Relation of Nathan B Fountain
Nathan B Fountain Owned Company Details
What does Acumen Pharmaceuticals Inc do?
Who are the key executives at Acumen Pharmaceuticals Inc?
Nathan B Fountain is the director of Acumen Pharmaceuticals Inc. Other key executives at Acumen Pharmaceuticals Inc include Chief Legal Office & Corp Sec Derek M Meisner , director & President and CEO Daniel Joseph Oconnell , and Chief Financial Officer Matt Zuga .
Acumen Pharmaceuticals Inc (ABOS) Insider Trades Summary
Over the past 18 months, Nathan B Fountain made no insider transaction in Acumen Pharmaceuticals Inc (ABOS). Other recent insider transactions involving Acumen Pharmaceuticals Inc (ABOS) include a net purchase of 5,161,290 shares made by Ra Capital Healthcare Fund Lp , a net sale of 41,949 shares made by Jeffrey L. Ives , and a net sale of 15,200 shares made by Daniel Joseph Oconnell .
In summary, during the past 3 months, insiders sold 0 shares of Acumen Pharmaceuticals Inc (ABOS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 76,281 shares of Acumen Pharmaceuticals Inc (ABOS) were sold and 5,161,290 shares were bought by its insiders, resulting in a net purchase of 5,085,009 shares.
Acumen Pharmaceuticals Inc (ABOS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Acumen Pharmaceuticals Inc Insider Transactions
Nathan B Fountain Mailing Address
Above is the net worth, insider trading, and ownership report for Nathan B Fountain. You might contact Nathan B Fountain via mailing address: C/o Acumen Pharmaceuticals, Inc., 427 Park Street, Charlottesville Va 22902.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
